AbbVie Inc. (ABBV) Comparison with companies in other sectors?

AbbVie Inc. has a share price of 1.77B. You can analyze AbbVie Inc. (ABBV) competitors across different market sectors through stock heatmaps.

What are ABBV's NET and operating margins?

AbbVie Inc. (ABBV) operating margin is around 0.28, and net profit margin is approximately 0.07 as of the latest reports.

In what way does ABBV's earnings per share (EPS) trend reflect its financial momentum?

AbbVie Inc. (ABBV) EPS is 2.34 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for AbbVie Inc. is 81.35, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for AbbVie Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for AbbVie Inc. like P/E which is 80.32, P/B which is 237.29, and PEG which is -38.71. Compare them with sector averages to evaluate if the stock is priced fairly.

AbbVie Inc.

ABBV•NYSE

Healthcare

Drug Manufacturers - General

$190.28

$-0.55(-0.29%)

Fundamental Analysis of AbbVie Inc. (ABBV)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$2.34

P/E Ratio

81.35

ROE

0.96%

Net Margin

0.07%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$336.23B

Shares OutstandingTotal number of shares issued

$1.77B

Book Value/ShareNet worth per share

$0.83

Revenue/ShareAnnual revenue per share

$32.45

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$2.34

Net MarginNet income as percentage of revenue

7.31%

Operating MarginOperating income as percentage of revenue

28.31%

ROEReturn on shareholders' equity

95.59%

ROAReturn on total assets

3.08%

ROCEReturn on capital employed

16.28%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$8.70

Cash/ShareCash and equivalents per share

$2.93

FCF YieldFree cash flow as percentage of market cap

4.56%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$6.47

Dividend YieldAnnual dividend as percentage of stock price

3.39%

Financial Ratios Analysis data is not available for ABBVFinancial Ratios Analysis details for ABBV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ABBVSector Benchmarking details for ABBV are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for AbbVie Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of AbbVie Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account AbbVie Inc.'s unique business strengths and challenges.

Key Financial Metrics for AbbVie Inc.

For AbbVie Inc., essential financial indicators include EPS 2.34, PE 81.35, and ROE 0.96. These key ratios reveal insights into AbbVie Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare AbbVie Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of AbbVie Inc.

Metrics like Net Margin 7.31% and ROA 3.08% shed light on how well AbbVie Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether AbbVie Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of AbbVie Inc.

Using ratios such as P/B Ratio 237.29 and PEG Ratio -38.71, investors can assess whether AbbVie Inc. is appropriately valued based on its financials and growth potential. These figures, combined with AbbVie Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for AbbVie Inc.

Financial health indicators, such as Debt/Equity Ratio 49.22 and Cash Flow $8.70, provide a snapshot of AbbVie Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like AbbVie Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for AbbVie Inc.

Investing in AbbVie Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at AbbVie Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;